Page last updated: 2024-09-03

n,n-dimethylarginine and Hyperlipoproteinemia Type II

n,n-dimethylarginine has been researched along with Hyperlipoproteinemia Type II in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armstrong, VW; Helfmann, J; Hintze, E; Konstantinides, S; Koziolek, MJ; Lange, K; Mueller, GA; Rossenbach, J; Schmitto, JD	1
Florkowski, CM; Frampton, CM; George, PM; Molyneux, SL; Reinheimer, AM; Scott, RS; Young, JM	1
Knuuti, J; Laakso, J; Laaksonen, R; Laine, H; Päivä, H; Raitakari, OT	1
Jehlicka, P; Mayer, O; Racek, J; Siala, K; Stožický, F; Trefil, L; Varvařovská, J	1

Trials

1 trial(s) available for n,n-dimethylarginine and Hyperlipoproteinemia Type II

Article	Year
Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1. Physiological research, 2009, Volume: 58, Issue:2 Topics: Adolescent; Anticholesteremic Agents; Arginine; Azetidines; Biomarkers; Child; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Risk Factors; Ultrasonography; Vitamin B Complex	2009

Article

Year

Asymmetric dimethylarginine and the effect of folate substitution in children with familial hypercholesterolemia and diabetes mellitus type 1.

Physiological research, 2009, Volume: 58, Issue:2

Topics: Adolescent; Anticholesteremic Agents; Arginine; Azetidines; Biomarkers; Child; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Endothelium, Vascular; Ezetimibe; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Risk Factors; Ultrasonography; Vitamin B Complex

2009

Other Studies

3 other study(ies) available for n,n-dimethylarginine and Hyperlipoproteinemia Type II

Article	Year
Lipid-apheresis improves microcirculation of the upper limbs. Journal of clinical apheresis, 2011, Volume: 26, Issue:4 Topics: Adult; Aged; Arginine; Atrial Natriuretic Factor; Blood Component Removal; Blood Flow Velocity; Endothelin-1; Epinephrine; Erythrocyte Aggregation; Female; Fibrinogen; Hand; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Laser-Doppler Flowmetry; Lipids; Male; Microcirculation; Microscopic Angioscopy; Middle Aged; Norepinephrine; Photoplethysmography	2011
Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapy. Atherosclerosis, 2011, Volume: 218, Issue:1 Topics: Aged; Arginine; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Genotype; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Mutation; Receptors, LDL; Ubiquinone; Vascular Stiffness	2011
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia. Journal of the American College of Cardiology, 2002, Oct-02, Volume: 40, Issue:7 Topics: Adult; Age Factors; Arginine; Biomarkers; Blood Flow Velocity; Case-Control Studies; Coronary Circulation; Cross-Sectional Studies; Dipyridamole; Humans; Hyperemia; Hyperlipoproteinemia Type II; Hypertension; Linear Models; Male; Multivariate Analysis; Nitric Oxide Synthase; Tomography, Emission-Computed; Vasodilator Agents	2002